Raphael Pharmaceutical Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Raphael Pharmaceutical Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Raphael Pharmaceutical Inc. Assets for the quarter ending September 30, 2024 was $51K, a 87.3% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$51K	-$352K	-87.3%	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$128K	+$9K	+7.56%	Jun 30, 2024	10-Q	2024-08-12
Q1 2024	$353K	+$203K	+135%	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$339K	+$6K	+1.8%	Dec 31, 2023	10-Q	2024-11-14
Q3 2023	$403K	+$282K	+233%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$119K	-$77K	-39.3%	Jun 30, 2023	10-Q	2023-08-09
Q1 2023	$150K	-$30K	-16.7%	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$333K	-$89K	-21.1%	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$121K	+$59K	+95.2%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$196K			Jun 30, 2022	10-Q	2022-08-12
Q1 2022	$180K			Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$422K	+$99K	+30.7%	Dec 31, 2021	10-K/A	2023-05-25
Q3 2021	$62K			Sep 30, 2021	10-Q	2021-11-16
Q4 2020	$323K			Dec 31, 2020	10-K	2022-03-30

* An asterisk sign (*) next to the value indicates that the value is likely invalid.